This is a glucagon receptor mediated effect that has no equivalent in tirzepatide therapy
Sci Rep 7:12571 Katakura Y, Totsuka M, Imabayashi E et al
To evaluate the convergence of published results, we first conduct a multi-level kernel density meta-analysis of studies reporting a positive association of ghrelin ( N comb = 353, 18 contrasts) and a negative association of GLP-1 ( N comb = 258, 12 contrasts) and reward responses measured using task functional magnetic resonance imaging (fMRI)
In type 2 diabetes trials (the SUSTAIN program), Ozempic produced an average weight loss of around 4.5 kg to 6.5 kg (roughly 10 to 14 lbs) over 52 weeks, depending on the dose
In clinical trials for weight management (SURMOUNT-1), participants without diabetes lost approximately 15% of body weight at 5 mg, 20% at 10 mg, and 21% at 15 mg over 72 weeks
Reconstitution Guidelines Standard peptide preparation procedures should be followed to ensure proper solubilization and stability